Journal: American Journal of Respiratory Cell and Molecular Biology
Article Title: Loss of CDKN2B Promotes Fibrosis via Increased Fibroblast Differentiation Rather Than Proliferation
doi: 10.1165/rcmb.2017-0298OC
Figure Lengend Snippet: Loss of CDKN2B in fibroblasts resulted in a decrease in cell proliferation. (A) Normal lung fibroblasts (CCL210) were treated with either control siRNA or siRNA against CDKN2B for 48 hours, and expression of various CDK inhibitors was assayed by RT-PCR (n = 4). (B–F) CCL210 fibroblasts were treated with either control or CDKN2B siRNA for 48 hours before treatment with either medium alone, platelet-derived growth factor (PDGF) (20 ng/ml), fibroblast growth factor (FGF) (25 ng/ml), transforming growth factor (TGF)-β1 (2 ng/ml), or Dulbecco’s modified Eagle medium (DMEM) with 10% serum for 24 hours. (B) Expression of CDKN2B was evaluated by immunoblot. Representative blot of four independent experiments is shown. (C) Cell proliferation was assayed by the CyQuant assay, as described in Methods, with values expressed as arbitrary fluorescent units. Data from a single experiment, which is representative of four independent experiments, are shown. Each experiment was performed in six replicate wells, with mean and SE measurements shown. (D) Levels of CCNB1 (cyclin B1) and CCND1 (cyclin D1) mRNA were assayed by RT-PCR (n = 8). (E) Cyclin B1 (n = 2) and (F) cyclin D1 (n = 3) protein were assayed by immunoblot with representative immunoblots shown. (G) Fibroblasts from wild-type and Cdkn2b−/− mice were assayed for cyclin D1 protein expression at baseline and in the presence of FGF (25 ng/ml). The mean of the relative densitometric values from three independent experiments are indicated below. (H) CDKN2B mRNA levels were assayed from fibroblasts of wild-type, Cdkn2b+/−, and Cdkn2b−/− mice in the presence or absence of TGF-β1 (2 ng/ml) or FGF (25 ng/ml). (I) Fibroblasts from wild-type, Cdkn2b+/−, and Cdkn2b−/− mice were assayed for proliferation by CyQuant assay in the presence of medium alone, FGF (25 ng/ml), PDGF (20 ng/ml), and 10% serum (representative experiment from four independent experiments). (J and K) BEAS-2B, a bronchial epithelial cell line, was treated with control or CDKN2B siRNA. Proliferation of cells in (J) bronchial epithelial growth medium (BEGM) was assayed by CyQuant assay (n = 3) and by expression of (K) cyclin D1 (n = 4). *P < 0.05, **P < 0.01, ***P < 0.001, Student’s t test (A, D, J, and K), one-way ANOVA with Tukey’s multiple comparisons test (C and F). arb = arbitrary; cont si = control siRNA; Rel exp = relative expression.
Article Snippet: Cell Culture Normal primary human lung fibroblasts (CCL210) and human bronchial epithelial cells (BEAS-2B) were obtained from American Type Culture Collection.
Techniques: Control, Expressing, Reverse Transcription Polymerase Chain Reaction, Derivative Assay, Modification, Western Blot, CyQUANT Assay